Tag: iShares U.S. Medical Devices ETF

J&J’s .6B Deal for Abiomed Indicators a New Concentration on Medtech

J&J’s $16.6B Deal for Abiomed Indicators a New Concentration on Medtech

by souhaib

November 1, 2022

Johnson & Johnson introduced an eye-popping health care-product enterprise acquisition early Tuesday, having to pay $16.6 billion upfront for Abiomed ...

Tag: iShares U.S. Medical Devices ETF

J&J’s $16.6B Deal for Abiomed Indicators a New Concentration on Medtech

Recommended

Pat Rafter’s warning for Alex de Minaur amid Lleyton Hewitt detail behind campaign

January 20 Weather Cold Weather Advisory And Gulf Coast Snowstorm

Broadcaster apologizes to Djokovic, Serbian fans for comments

Analysis: Trump’s comeback will begin with a blast of executive power

Recent Posts

Categories